Unibest 优贝德
← Back to patent-cliff list

阿贝西利

Tier A — Act now

Abemaciclib · all drugs expiring in 2029 →

礼来制药
Originator
2017
First approval
2029
Expiry (public)
$5.72B ▲
Peak sales
化学药
Type

TargetsCDK6、CDK4

Brand唯择、Verzenios、Verzenio

Indications (approved)乳腺癌

Regional status

US
批准上市
2017-09-28
EU
批准上市
2018-09-26
China
批准上市
2020-12-30
Japan
批准上市
2018-09-21

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 9 · Total yield 20.4 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
ABEM-00175-31-0Availablepropan-2-amine
ABEM-0021118-69-0AvailableN-isopropylacetamide
ABEM-00367567-26-4Available4-bromo-2,6-difluoroaniline
ABEM-0041231930-29-2Available(E)-N'-(4-bromo-2,6-difluorophenyl)-N-isopropylacetimidamide
ABEM-0051231930-33-8Available6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
ABEM-00673183-34-3Available4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane)
ABEM-0071231930-37-2Available4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole
ABEM-0082927-71-1Available2,4-dichloro-5-fluoropyrimidine
ABEM-0091231930-42-9Available6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
ABEM-0101180132-17-5Available5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-amine
ABEM-0115308-25-8Available1-ethylpiperazine
ABEM-012149806-06-4Available6-bromonicotinaldehyde
ABEM-0131231930-25-8Available1-((6-bromopyridin-3-yl)methyl)-4-ethylpiperazine
OptimisedRoute 2Steps 3 · Total yield /
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
ABEM-0071231930-37-2Available4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole
ABEM-0082927-71-1Available2,4-dichloro-5-fluoropyrimidine
ABEM-0091231930-42-9Available6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
ABEM-0115308-25-8Available1-ethylpiperazine
ABEM-01469879-22-7Available6-aminonicotinaldehyde
ABEM-0151627082-92-1Available6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)nicotinaldehyde

Frequently asked questions

What are the approved indications of Abemaciclib?

Approved indications include: 乳腺癌.

When does the Abemaciclib patent expire?

Based on public sources, the Abemaciclib patent expires in 2029.

How many synthesis routes are recorded for Abemaciclib?

2 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Abemaciclib intermediates?

15 intermediate CAS of Abemaciclib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Abemaciclib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24